We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lockheed Martin
LMT
$138B
| $30.7M | 0.22% |
66,651
-1,091
| -2% | -$506K |
|
77
GE Aerospace
GE
$375B
| $30.4M | 0.22% |
346,211
-8,927
| -3% | -$723K |
|
78
Medtronic
MDT
$116B
| $29.7M | 0.22% |
337,648
-5,778
| -2% | -$497K |
|
79
Booking.com
BKNG
$161B
| $29.5M | 0.22% |
273,175
-15,875
| -5% | -$1.68M |
|
80
AT&T
T
$169B
| $28.9M | 0.21% |
1,814,793
-25,472
| -1% | -$434K |
|
81
TJX Companies
TJX
$169B
| $28.9M | 0.21% |
340,271
-4,390
| -1% | -$346K |
|
82
Prologis
PLD
$134B
| $28.7M | 0.21% |
234,378
-3,798
| -2% | -$467K |
|
83
Morgan Stanley
MS
$344B
| $28.1M | 0.2% |
328,661
-6,993
| -2% | -$598K |
|
84
American Express
AXP
$233B
| $27.7M | 0.2% |
158,948
+3,810
| +2% | +$615K |
|
85
Stryker
SYK
$131B
| $27.4M | 0.2% |
89,858
-4,956
| -5% | -$1.43M |
|
86
Elevance Health
ELV
$86.4B
| $27.3M | 0.2% |
61,485
-3,126
| -5% | -$1.44M |
|
87
Goldman Sachs
GS
$304B
| $27.2M | 0.2% |
84,193
-2,982
| -3% | -$980K |
|
|
MRSH
88
Marsh
MRSH
$89.9B
| $26.7M | 0.19% |
142,097
-3,319
| -2% | -$589K |
|
89
American Tower
AMT
$81.5B
| $26.7M | 0.19% |
137,683
+3,342
| +2% | +$653K |
|
90
Vertex Pharmaceuticals
VRTX
$131B
| $26.5M | 0.19% |
75,198
-762
| -1% | -$257K |
|
91
Automatic Data Processing
ADP
$109B
| $26.3M | 0.19% |
119,655
-2,653
| -2% | -$572K |
|
92
Blackrock
BLK
$183B
| $26.3M | 0.19% |
37,993
-627
| -2% | -$420K |
|
|
93
iShares MSCI EAFE ETF
EFA
$80.4B
| $25.7M | 0.19% |
354,000
+125,000
| +55% | +$9.08M |
|
94
Lam Research
LRCX
$423B
| $25.3M | 0.18% |
393,910
-8,120
| -2% | -$458K |
|
95
Mondelez International
MDLZ
$80.8B
| $25.2M | 0.18% |
345,630
-6,213
| -2% | -$459K |
|
96
Analog Devices
ADI
$186B
| $25M | 0.18% |
128,391
-6,451
| -5% | -$1.19M |
|
97
Gilead Sciences
GILD
$170B
| $24.4M | 0.18% |
316,655
-5,343
| -2% | -$426K |
|
98
Zoetis
ZTS
$31B
| $23.5M | 0.17% |
136,596
-2,586
| -2% | -$447K |
|
|
99
Palo Alto Networks
PANW
$322B
| $22.8M | 0.17% |
178,292
+142,226
| +394% | +$14.8M |
|
100
Citigroup
C
$233B
| $22.7M | 0.17% |
494,093
-5,748
| -1% | -$269K |
|
Similar funds
PCM
CS
HHII
EIM
P
BPA
NAM
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.